Trial Profile
A Phase 3, Multi Centre, Open label, Parallel, Two Groups, Multi Arm, Randomized, Registration Clinical Study to Evaluate the Efficacy and Safety of Colesevelam Hydrochloride as Combination Therapy in Adult Indian Non Diabetic Patients with Primary Hyperlipidemia and Type II Diabetic Patients with Primary Hyperlipidemia
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 30 Aug 2016
Price :
$35
*
At a glance
- Drugs Colesevelam (Primary) ; HMG-CoA reductase inhibitors; Metformin
- Indications Hyperlipidaemia; Type 2 diabetes mellitus
- Focus Therapeutic Use
- 28 Sep 2011 New trial record